Publications by authors named "Lemuel A Moye"

Claim this Profile
A
Applications of Covariate Adjusted Nonparametric Methods to CCTRN Clinical Trials.
Jiabu Ye, Dejian Lai, Lemuel A Moye, Barry R Davis

Commun Stat Case Stud Data Anal Appl· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autism spectrum disorder reporting in lower socioeconomic neighborhoods.
Aisha S Dickerson, Mohammad H Rahbar, Deborah A Pearson, Russell S Kirby, Amanda V Bakian

Autism· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic.
Aisha S Dickerson, Mohammad H Rahbar, Amanda V Bakian, Deborah A Bilder, Rebecca A Harrington

Environ Monit Assess· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies.
Mariann Gyöngyösi, Wojciech Wojakowski, Eliano P Navarese, Lemuel À Moye,

Circ Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autism spectrum disorder prevalence and proximity to industrial facilities releasing arsenic, lead or mercury.
Aisha S Dickerson, Mohammad H Rahbar, Inkyu Han, Amanda V Bakian, Deborah A Bilder

Sci Total Environ· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
Mariann Gyöngyösi, Wojciech Wojakowski, Patricia Lemarchand, Ketil Lunde, Michal Tendera

Circ Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.
Deborah D Ascheim, Annetine C Gelijns, Daniel Goldstein, Lemuel A Moye, Nicholas Smedira

Circulation· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Robert D Simari, Carl J Pepine, Jay H Traverse, Timothy D Henry, Roberto Bolli

Circ Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal allocation of sample sizes to multicenter clinical trials.
Dejian Lai, Kuang-Chao Chang, Mohammad H Rahbar, Lemuel A Moye

J Biopharm Stat· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN.
Ki E Park, Lemuel A Moyé, Timothy D Henry, Emerson C Perin, Shelly L Sayre

Expert Rev Cardiovasc Ther· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials.
Anita D Szady, Carl J Pepine, Shreela V Sharma, Christopher R Cogle, Emerson C Perin

Curr Atheroscler Rep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow-derived cell therapy after myocardial infarction.
Lemuel A Moyé, Robert D Simari, Sonia I Skarlatos,

JAMA· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).
Joshua M Hare, Roberto Bolli, John P Cooke, David J Gordon, Timothy D Henry

Circulation· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
Jay H Traverse, Timothy D Henry, Carl J Pepine, James T Willerson, David X M Zhao

JAMA· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Sara Richman, Adrian P Gee, David H McKenna, Jay H Traverse, Timothy D Henry

Transfusion· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.
Martin Rodriguez-Porcel, Marvin W Kronenberg, Timothy D Henry, Jay H Traverse, Carl J Pepine

JACC Cardiovasc Imaging· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
Emerson C Perin, James T Willerson, Carl J Pepine, Timothy D Henry, Stephen G Ellis

JAMA· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining censored and uncensored data in a U-statistic: design and sample size implications for cell therapy research.
Lemuel A Moyé, Dejian Lai, Kaiyan Jing, Mary Sarah Baraniuk, Minjung Kwak

Int J Biostat· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rudiments of subgroup analyses.
Lemuel A Moyé

Prog Cardiovasc Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
Claudia Zierold, Marjorie A Carlson, Udo C Obodo, Elizabeth Wise, Victor A Piazza

Am Heart J· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experience.
Lemuel A Moyé, Timothy D Henry, Kenneth W Baran, Judy Bettencourt, Barb Bruhn-Ding

Contemp Clin Trials· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
Jay H Traverse, Timothy D Henry, Stephen G Ellis, Carl J Pepine, James T Willerson

JAMA· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
Jay H Traverse, Timothy D Henry, Lemuel A Moye'

Am Heart J· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oversight and management of a cell therapy clinical trial network: experience and lessons learned.
Lemuel A Moyé, Shelly L Sayre, Lynette Westbrook, Beth C Jorgenson, Eileen Handberg

Contemp Clin Trials· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network.
John W Petersen, John R Forder, James D Thomas, Lemuel A Moyé, Mark Lawson

JACC Cardiovasc Imaging· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis